Tacalcitol: A Versatile Compound for Medical Research

Tacalcitol,CAS:57333-96-7  is a synthetic analog of vitamin D3 that has gained significant attention in the field of medical research. With its unique properties and potential therapeutic applications, Tacalcitol offers researchers a valuable tool for investigating various diseases and conditions.Properties and Mechanism of Action:Tacalcitol acts as a selective agonist for the vitamin D receptor (VDR), which plays a crucial role in regulating gene expression and immune response modulation. By binding to the VDR, Tacalcitol exerts immunomodulatory and anti-inflammatory effects.Applica [...]

Methyl 2,5,6-Trichloropyrimidine-4-carboxylate,Cas:89284-85-5: A Versatile Chemical Compound

Methyl 2,5,6-Trichloropyrimidine-4-carboxylate 89284-85-5: A Versatile Chemical Compound | Available at Finetech Industry LimitedIntroduction:Methyl 2,5,6-trichloropyrimidine-4-carboxylate is a chemical compound known for its versatility and wide-ranging applications. At FINETECH Industry Limited, we offer this compound to meet the diverse needs of industries. This article provides an overview of methyl 2,5,6-trichloropyrimidine-4-carboxylate, including its structure, synthesis methods, and potential applications, highlighting how you can contact us for your requirements.Chemical Structure:Met [...]

High-Quality CTLA-4 Inhibitor (CAS: 635324-72-0) – Available at Finetech Industry Limited

🔬 Advancing Immunotherapy Research with CTLA-4 Inhibitors 🔬At Finetech Industry Limited, we are committed to providing high-purity research chemicals for cutting-edge scientific advancements. One of our key offerings is CTLA-4 Inhibitor (CAS: 635324-72-0), a promising compound in the field of immunotherapy and oncology research.Product Details🔹 Chemical Name: 2-(4-fluorophenyl)-6-methyl-4-(3-(trifluoromethyl)phenyl)-1,2-dihydrodipyrazolo[3,4-b:3',4'-d]pyridin-3(6H)-one🔹 CAS Number: 635324-72-0🔹 Purity: High-purity, research-grade🔹 Application: Immuno-oncology, autoimmune disease research, and [...]